Probiotic Monotherapy with Lactobacillus reuteri (Prodentis) as a Coadjutant to Reduce Subgingival Dysbiosis in a Patient with Periodontitis
Abstract
:1. Introduction
2. Materials and Methods
2.1. Case Report
2.2. Clinical Case Description and Probiotic Adjuvant
2.3. Clinical Periodontal Evaluation and Microbial Assessment
2.4. Statistical Analysis
3. Results
3.1. Clinical Periodontal Characteristics
3.2. Mean Total Levels of Full Mouth and Tooth 46
3.3. Mean Individual Levels and Proportion of Full Mouth and Tooth 46
3.4. Mean Proportions of Microbial Complexes
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Tonetti, M.S.; Jepsen, S.; Jin, L.; Otomo-Corgel, J. Impact of the global burden of periodontal diseases on health, nutrition and wellbeing of mankind: A call for global action. J. Clin. Periodontol. 2017, 44, 456–462. [Google Scholar] [CrossRef] [Green Version]
- Khanna, S.; Tosh, P.K. A clinician’s primer on the role of the microbiome in human health and disease. Mayo Clin. Proc. 2014, 89, 107–114. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Deng, Z.-L.; Szafrański, S.P.; Jarek, M.; Bhuju, S.; Wagner-Döbler, I. Dysbiosis in chronic periodontitis: Key microbial players and interactions with the human host. Sci. Rep. 2017, 7, 3703. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Papapanou, P.N.; Sanz, M.; Buduneli, N.; Dietrich, T.; Feres, M.; Fine, D.H.; Flemmig, T.F.; Garcia, R.; Giannobile, W.V.; Graziani, F. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J. Periodontol. 2018, 89, S173–S182. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Socransky, S.S.; Haffajee, A.D. Periodontal microbial ecology. Periodontol 2000 2005, 38, 135–187. [Google Scholar] [CrossRef]
- Genco, R.J.; Sanz, M. Clinical and public health implications of periodontal and systemic diseases: An overview. Periodontology 2000 2020, 83, 7–13. [Google Scholar] [CrossRef]
- Martínez-García, M.; Hernández-Lemus, E. Periodontal inflammation and systemic diseases: An overview. Front. Physiol. 2021, 12, 1842. [Google Scholar] [CrossRef]
- Peres, M.A.; Macpherson, L.M.; Weyant, R.J.; Daly, B.; Venturelli, R.; Mathur, M.R.; Listl, S.; Celeste, R.K.; Guarnizo-Herreño, C.C.; Kearns, C. Oral diseases: A global public health challenge. Lancet 2019, 394, 249–260. [Google Scholar] [CrossRef]
- Claffey, N.; Polyzois, I.; Ziaka, P. An overview of nonsurgical and surgical therapy. Periodontology 2000 2004, 36, 35–44. [Google Scholar] [CrossRef]
- Feng, P.; Ye, Z.; Kakade, A.; Virk, A.K.; Li, X.; Liu, P. A review on gut remediation of selected environmental contaminants: Possible roles of probiotics and gut microbiota. Nutrients 2018, 11, 22. [Google Scholar] [CrossRef] [Green Version]
- Nguyen, T.; Brody, H.; Lin, G.H.; Rangé, H.; Kuraji, R.; Ye, C.; Kamarajan, P.; Radaic, A.; Gao, L.; Kapila, Y. Probiotics, including nisin-based probiotics, improve clinical and microbial outcomes relevant to oral and systemic diseases. Periodontology 2000 2020, 82, 173–185. [Google Scholar] [CrossRef] [PubMed]
- Ikram, S.; Hassan, N.; Baig, S.; Borges, K.J.J.; Raffat, M.A.; Akram, Z. Effect of local probiotic (Lactobacillus reuteri) vs systemic antibiotic therapy as an adjunct to non-surgical periodontal treatment in chronic periodontitis. J. Investig. Clin. Dent. 2019, 10, e12393. [Google Scholar] [CrossRef] [PubMed]
- Tekce, M.; Ince, G.; Gursoy, H.; Dirikan Ipci, S.; Cakar, G.; Kadir, T.; Yilmaz, S. Clinical and microbiological effects of probiotic lozenges in the treatment of chronic periodontitis: A 1-year follow-up study. J. Clin. Periodontol. 2015, 42, 363–372. [Google Scholar] [CrossRef] [PubMed]
- Vicario, M.; Santos, A.; Violant, D.; Nart, J.; Giner, L. Clinical changes in periodontal subjects with the probiotic Lactobacillus reuteri Prodentis: A preliminary randomized clinical trial. Acta Odontol. Scand. 2013, 71, 813–819. [Google Scholar] [CrossRef]
- Ahuja, A.; Ahuja, V. Efficacy of probiotic Lactobacillus reuteri on chronic generalised periodontitis: A systematic review of randomized controlled clinical trials in humans. J. Dent. Panacea 2021, 3, 106–117. [Google Scholar] [CrossRef]
- Iniesta, M.; Herrera, D.; Montero, E.; Zurbriggen, M.; Matos, A.R.; Marin, M.J.; Sanchez-Beltran, M.C.; Llama-Palacio, A.; Sanz, M. Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial. J. Clin. Periodontol. 2012, 39, 736–744. [Google Scholar] [CrossRef]
- Sinkiewicz, G.; Cronholm, S.; Ljunggren, L.; Dahlen, G.; Bratthall, G. Influence of dietary supplementation with Lactobacillus reuteri on the oral flora of healthy subjects. Swed. Dent. J. 2010, 34, 197–206. [Google Scholar]
- Hallström, H.; Lindgren, S.; Yucel-Lindberg, T.; Dahlén, G.; Renvert, S.; Twetman, S. Effect of probiotic lozenges on inflammatory reactions and oral biofilm during experimental gingivitis. Acta Odontol. Scand. 2013, 71, 828–833. [Google Scholar] [CrossRef]
- Rodríguez-Hernández, A.-P.; Márquez-Corona, M.d.L.; Pontigo-Loyola, A.P.; Medina-Solís, C.E.; Ximenez-Fyvie, L.-A. Subgingival microbiota of Mexicans with type 2 diabetes with different periodontal and metabolic conditions. Int. J. Environ. Res. Public Health 2019, 16, 3184. [Google Scholar] [CrossRef] [Green Version]
- Ishikawa, H.; Akedo, I.; Umesaki, Y.; Tanaka, R.; Imaoka, A.; Otani, T. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J. Am. Coll. Nutr. 2003, 22, 56–63. [Google Scholar] [CrossRef]
- Koebnick, C.; Wagner, I.; Leitzmann, P.; Stern, U.; Zunft, H. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can. J. Gastroenterol. Hepatol. 2003, 17, 655–659. [Google Scholar]
- Koll, P.; Mändar, R.; Marcotte, H.; Leibur, E.; Mikelsaar, M.; Hammarström, L. Characterization of oral lactobacilli as potential probiotics for oral health. Oral Microbiol. Immunol. 2008, 23, 139–147. [Google Scholar] [CrossRef] [PubMed]
- Mayanagi, G.; Kimura, M.; Nakaya, S.; Hirata, H.; Sakamoto, M.; Benno, Y.; Shimauchi, H. Probiotic effects of orally administered Lactobacillus salivarius WB21-containing tablets on periodontopathic bacteria: A double-blinded, placebo-controlled, randomized clinical trial. J. Clin. Periodontol. 2009, 36, 506–513. [Google Scholar] [CrossRef] [PubMed]
- Herrera, D.; Retamal-Valdes, B.; Alonso, B.; Feres, M. Acute periodontal lesions (periodontal abscesses and necrotizing periodontal diseases) and endo-periodontal lesions. J. Clin. Periodontol. 2018, 45, S78–S94. [Google Scholar] [CrossRef] [Green Version]
- Teughels, W.; Durukan, A.; Ozcelik, O.; Pauwels, M.; Quirynen, M.; Haytac, M.C. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: A randomized placebo-controlled study. J. Clin. Periodontol. 2013, 40, 1025–1035. [Google Scholar] [CrossRef] [Green Version]
- Vivekananda, M.R.; Vandana, K.L.; Bhat, K.G. Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: A preliminary randomized clinical trial. J. Oral Microbiol. 2010, 2, 5344. [Google Scholar] [CrossRef]
- Socransky, S.; Haffajee, A.; Smith, C.; Martin, L.; Haffajee, J.; Uzel, N.; Goodson, J. Use of checkerboard DNA–DNA hybridization to study complex microbial ecosystems. Oral Microbiol. Immunol. 2004, 19, 352–362. [Google Scholar] [CrossRef]
- Teles, F.R. The microbiome of peri-implantitis: Is it unique. Compend. Contin. Educ. Dent. 2017, 38, 22–25. [Google Scholar]
- Martellacci, L.; Quaranta, G.; Patini, R.; Isola, G.; Gallenzi, P.; Masucci, L. A literature review of metagenomics and culturomics of the peri-implant microbiome: Current evidence and future perspectives. Materials 2019, 12, 3010. [Google Scholar] [CrossRef] [Green Version]
- Schierz, O.; Baba, K.; Fueki, K. Functional oral health-related quality of life impact: A systematic review in populations with tooth loss. J. Oral Rehabil. 2021, 48, 256–270. [Google Scholar] [CrossRef]
- Dassi, E.; Ferretti, P.; Covello, G.; Bertorelli, R.; Denti, M.A.; De Sanctis, V.; Tett, A.; Segata, N. The short-term impact of probiotic consumption on the oral cavity microbiome. Sci. Rep. 2018, 8, 10476. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Marouf, N.; Cai, W.; Said, K.N.; Daas, H.; Diab, H.; Chinta, V.R.; Hssain, A.A.; Nicolau, B.; Sanz, M.; Tamimi, F. Association between periodontitis and severity of COVID-19 infection: A case–control study. J. Clin. Periodontol. 2021, 48, 483–491. [Google Scholar] [CrossRef] [PubMed]
Species | ATCC | Complex | Species | ATCC | Complex |
---|---|---|---|---|---|
Actinomyces georgiae | 49285 | Actinomyces | Neisseria mucosa | 19696 | Other |
Actinomyces israelii | 12102 | Actinomyces | Parvimonas micra | 33270 | Orange |
Actinomyces naeslundii | 12104 | Actinomyces | Porphyromonas endodontalis | 35406 | Other |
Actinomyces odontolyticus | 17929 | Purple | Porphyromonas gingivalis | 33277 | Red |
Actinomyces viscosus | 43146 | Actinomyces | Prevotella intermedia | 25611 | Orange |
Aggregatibacter actinomycetemcomitans stp. b. | 43718 | Ungrouped | Prevotella melaninogenica | 25845 | Other |
Campylobacter gracilis | 33236 | Orange | Prevotella nigrescens | 33563 | Orange |
Campylobacter rectus | 33238 | Orange | Propionibacterium acnes | 6919 | Other |
Campylobacter showae | 51146 | Orange | Selenomonas artemidis | 43528 | Other |
Capnocytophaga gingivalis | 33624 | Green | Selenomonas noxia | 43541 | Ungrouped |
Capnocytophaga ochracea | 27872 | Green | Streptococcus anginosus | 33397 | Yellow |
Capnocytophaga sputigena | 33612 | Green | Streptococcus constellatus | 27823 | Orange |
Corynebacterium matruchotii | 14266 | Other | Streptococcus gordonii | 10558 | Yellow |
Eikenella corrodens | 23834 | Green | Streptococcus intermedius | 27335 | Yellow |
Eubacterium saburreum | 33271 | Other | Streptococcus mitis | 49456 | Yellow |
Eubacterium sulci | 35585 | Other | Streptococcus oralis | 35037 | Yellow |
Fusobacterium nucleatum subsp. nucleatum | 25586 | Orange | Streptococcus sanguinis | 10556 | Yellow |
Fusobacterium periodonticum | 33693 | Orange | Tannerella forsythia | 43037 | Red |
Gemella morbillorum | 27824 | Other | Treponema denticola | 35405 | Red |
Leptotrichia buccalis | 14201 | Other | Veillonella parvula | 10790 | Purple |
Full Mouth | T0 | T1 | T2 | |||
---|---|---|---|---|---|---|
Media | ±SEM | Media | ±SEM | Media | ±SEM | |
Mean pocket depth (millimeters, mm) | 3.9 | 0.2 | 3.3 | 0.2 | 3.4 | 0.2 |
Mean attachment level (AL, mm) | 2 | 0.2 | 1.6 | 0.1 | 2.0 | 0.2 |
Mean number sites with AL ≥ 5 mm | 8 | 1.1 | 4 | 1.5 | 6 | 1.4 |
% sites with: | ||||||
Plaque accumulation (percent, %) | 14.5 | 0.7 | 8.7 | 1.1 | 14.5 | 0.7 |
**, ‡ Gingival erythema (%) | 45.7 | 0.1 | 44.2 | 0.1 | 69.6 | 0.1 |
* Bleeding on probing (%) | 74.6 | 0.1 | 58 | 0.1 | 98.6 | 0 |
Suppuration (%) | 17.4 | 0.1 | 25.4 | 0.1 | 24.6 | 0.1 |
Tooth 46 | T0 | T1 | T2 | |||
Media | ±SEM | Media | ±SEM | Media | ±SEM | |
Mean pocket depth (mm) | 10.2 | 1.6 | 8.9 | 1.8 | 8.8 | 1.7 |
Mean attachment level (AL, mm) | 7.4 | 1.5 | 6.3 | 1.5 | 6.7 | 1.6 |
Mean number sites with AL ≥ 5 mm | 4 | 1.2 | 3 | 0.3 | 3 | 0.6 |
% sites with: | ||||||
Plaque accumulation (%) | 33.3 | 0.2 | 16.7 | 0.2 | 50 | 0.2 |
∞, † Gingival erythema (%) | 100 | 0.0 | 16.7 | 0.2 | 100 | 0 |
Bleeding on probing (%) | 33.3 | 0.2 | 33.3 | 0.2 | 66.7 | 0.2 |
Suppuration (%) | 0.5 | 0.2 | 0 | 0 | 0 | 0 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Salinas-Azuceno, C.; Martínez-Hernández, M.; Maldonado-Noriega, J.-I.; Rodríguez-Hernández, A.-P.; Ximenez-Fyvie, L.-A. Probiotic Monotherapy with Lactobacillus reuteri (Prodentis) as a Coadjutant to Reduce Subgingival Dysbiosis in a Patient with Periodontitis. Int. J. Environ. Res. Public Health 2022, 19, 7835. https://doi.org/10.3390/ijerph19137835
Salinas-Azuceno C, Martínez-Hernández M, Maldonado-Noriega J-I, Rodríguez-Hernández A-P, Ximenez-Fyvie L-A. Probiotic Monotherapy with Lactobacillus reuteri (Prodentis) as a Coadjutant to Reduce Subgingival Dysbiosis in a Patient with Periodontitis. International Journal of Environmental Research and Public Health. 2022; 19(13):7835. https://doi.org/10.3390/ijerph19137835
Chicago/Turabian StyleSalinas-Azuceno, Claudia, Miryam Martínez-Hernández, José-Isaac Maldonado-Noriega, Adriana-Patricia Rodríguez-Hernández, and Laurie-Ann Ximenez-Fyvie. 2022. "Probiotic Monotherapy with Lactobacillus reuteri (Prodentis) as a Coadjutant to Reduce Subgingival Dysbiosis in a Patient with Periodontitis" International Journal of Environmental Research and Public Health 19, no. 13: 7835. https://doi.org/10.3390/ijerph19137835
APA StyleSalinas-Azuceno, C., Martínez-Hernández, M., Maldonado-Noriega, J. -I., Rodríguez-Hernández, A. -P., & Ximenez-Fyvie, L. -A. (2022). Probiotic Monotherapy with Lactobacillus reuteri (Prodentis) as a Coadjutant to Reduce Subgingival Dysbiosis in a Patient with Periodontitis. International Journal of Environmental Research and Public Health, 19(13), 7835. https://doi.org/10.3390/ijerph19137835